Study improves peptide proteolytic stability through backbone N-heteroatom substitution, suggesting a new strategy for therapeutic development.
Peptide-based ligands are well-suited to engage large biomolecular surfaces but are often limited by rapid proteolytic degradation in biological environments. Backbone modification offers a direct means to disrupt protease recognition...
No takes yet. Share an insight, caveat, or question.
Anwar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: